Table 2 Comparison of outcomes between two groups.
Complications | TE/I group | DIEP group | p-value |
|---|---|---|---|
Major complication | 112 (9.6%) | 14 (4.5%) | 0.004 |
Type | |||
Infection | 43 (3.7%) | 2 (0.6%) | |
Hematoma | 15 (1.3%) | 3 (1.0%) | |
Extensive wound problem | 0 | 1 (0.3%) | |
Flap failure | 0 | 2 (0.6%) | |
Fat necrosis excision* | 0 | 4 (1.3%) | |
Abdominal wall weakness | 0 | 2 (0.6%) | |
Prosthesis failure (rupture or leakage) | 13 (1.1%) | 0 | |
Capsular contracture | 19 (1.6%) | 0 | |
Unplanned conversion to other modalities | 22 (1.9%) | 0 | |
Timing | 0.019 | ||
Developed within postop 2 months | 39 (3.4%) | 8 (2.6%) | |
Developed within postop 2 years | 47 (4.0%) | 4 (1.3%) | |
Developed beyond postop 2 years | 26 (2.2%) | 2 (0.6%) | |
2-year cumulative incidence | 7.4% | 3.9% | |
5-year cumulative incidence | 10.3% | 4.7% | |
Reconstruction failure | 64 (5.5%) | 2 (0.6%) | < 0.001 |
Timing | 0.002 | ||
Developed within postop 2 months | 14 (1.2%) | 2 (0.6%) | |
Developed within postop 2 years | 39 (3.4%) | 0 | |
Developed beyond postop 2 years | 11 (0.9%) | 0 | |
Reoperation/Readmission for aesthetic purpose | 16 (1.4%) | 7 (2.2%) | 0.273 |
